Guidance

COVID-19 surveillance and immunity studies

An overview of national surveillance programmes that explain the transmission of COVID-19 and other priority infections and how they are affecting the wider population.

Documents

Details

This guidance of the UK’s COVID-19 surveillance and immunity studies is for healthcare professionals, academics, industry and the general public.

Programmes are managed by the UK Health Security Agency (UKHSA) in collaboration with a number of delivery partners, including the Office for National Statistics (ONS), research, academic and commercial partners.

Published 13 October 2020
Last updated 21 December 2023 + show all updates
  1. Added links to Winter CIS: UKHSA publications and Vivaldi social care – UCL to 'COVID-19 surveillance and immunity studies up to March 2024'.

  2. Added links with further information to 'COVID-19 surveillance and immunity studies up to March 2024'.

  3. Added COVID-19 surveillance and immunity studies up to March 2024.

  4. Updated COVID-19 surveillance and immunity studies up to March 2023.

  5. Added update on pausing data collection for the COVID-19 Infection Survey.

  6. Updated COVID-19 surveillance and immunity studies up to March 2022.

  7. Updated 'Living with COVID-19' information under Details.

  8. Updated 'COVID-19 surveillance and immunity studies', added 'COVID-19 surveillance and immunity studies up to March 2022'.

  9. Added CoMix study.

  10. Added information on Schools Infection Survey and PITCH. Added link to COVID-19 paediatric surveillance.

  11. Added link to the Vivaldi 3 study: Boosters strongly enhance SARS-CoV-2 antibody and cellular responses in elderly residents in care homes.

  12. Added link to the Vivaldi 3 study research findings.

  13. Added link to research findings: round 6.

  14. Added a link to Lay summaries on the Vivaldi 2 study on the University College London website.

  15. Added link to Schools Infection Survey research findings: round 5.

  16. Added a link to 'SIREN study - one year on' YouTube video.

  17. Updated descriptions for React studies, Vivaldi studies and the Schools Infection Survey to represent their current scope.

  18. Added link to 'COVID-19 Schools Infection Survey: round 2'.

  19. Updated to add a link to the Vivaldi 2 study research findings.

  20. Updated to include FAQs for the Vivaldi study, Schools Infection Survey and the UK Biobank SARS-CoV-2 serology study.

  21. Updated to add further reports and documentation on the studies.

  22. Information updated to reflect further research findings, additional studies and improvement in scope of existing studies.

  23. Links added to the document: press releases to REACT-1 and related content links at the end of the document.

  24. First published.